-
Trump under pressure from all sides over Chinese AI surge
-
Is 'superstar' Pogacar's Tour de France domination boring?
-
ICC member states decide fate of embattled prosecutor Karim Khan
-
Iran ramps up executions under shadow of war
-
Dodgers return to Trump White House despite fan anger
-
Rosalia's Argentine fans up in arms over alleged World Cup snub
-
Lyles, Richardson ease into 100m semis at US athletics championships
-
Six candidates to lead UN take stage for televised debate
-
Salman Rushdie testifies at knife attacker's US terror trial
-
King Charles opens slimmed down Commonwealth Games in Glasgow
-
World Bank confirms plan to phase out China lending by 2031
-
US unveils new tariffs on 60 partners as Trump rebuilds trade agenda
-
US panel backs trendy peptides despite safety concerns
-
WNBA viral star Cunningham wades into trans athletes row
-
Justice Dept withdraws NY Times subpoenas over Trump plane report
-
Hearn dismisses Fury talk of Joshua no-show for super fight
-
Barcelona's De Jong returns from World Cup with torn ligament
-
'Like a war zone': France evacuates 20,000 due to wildfires
-
Albania police teargas protesters against Trump-linked resort
-
Ships avoid Ukrainian grain ports after Russian attacks
-
US panel says to loosen restrictions on popular peptide despite safety concerns
-
Oil passes $100 a barrel again: why it's more serious this time
-
Verstappen swerves around future questions
-
Who are the six candidates vying to lead the UN?
-
EU renews online child sex abuse detection powers
-
Hamilton proud of recovery after hitting rock bottom a year ago
-
Airbus, Boeing fly in different directions at Farnborough
-
Carapaz eyes polkadot mountains jersey after stage win
-
Bab al-Mandeb Strait: another key oil shipping route under threat
-
Fields medal awarded to four young mathematicians
-
Deadly wildfires in Europe force thousands to flee
-
Carapaz claims Tour de France stage as Pogacar loses key team-mate
-
NATO to overhaul European fuel pipeline network
-
Alonso welcomes Aston Martin upgrade, warns against unreal expectations
-
US trade envoy to make tariff announcement as 10% duty soon expires
-
Anderson declares Man City 'kings of Manchester' after £116 mn move
-
Trump stuns Saudis by pinning nuclear deal to Israel ties
-
Relieved Russell says Mercedes have solved his power problems mystery
-
Tough day for Ubisoft stock topped with weaker revenues
-
Oil soars above $100 as Middle East fears grow
-
Swelling jet fuel costs hit American Airlines outlook
-
Venezuelans turn to scrap collecting in quake-hit beach 'paradise'
-
Carapaz climbs unopposed to Tour de France 18th stage win
-
Heptathlon champion Johnson-Thompson joins list of Commonwealth Games absentees
-
Sooryavanshi hits maiden 50 as India thump Zimbabwe in T20
-
Nigeria's Dangote raises $2.5bn to expand Africa's largest refinery
-
ECB opens door to September rate-hike as Iran war flares up
-
Oil soars to $100 on fresh Mideast attacks
-
World Bank estimates Venezuela quakes caused $19.6 bn in damage
-
Coal-fired power generation rising globally on Mideast war: IEA
Cancer, cardiovascular drugs tipped for Nobel as prize week opens
Cancer research or drugs treating cardiovascular illnesses could win a Nobel Prize on Monday when a week of laureate announcements kicks off, bringing a ray of optimism to a world beset by crises.
Awarded since 1901, the Nobel Prizes honour those who have, in the words of prize creator and scientist Alfred Nobel, "conferred the greatest benefit on humankind", highlighting encouraging advances at a time when the world is witnessing devastating wars in the Middle East and Ukraine and a climate on the brink of collapse.
The Nobel Prize in Medicine is first out, announced on Monday around 11:30 am (0930 GMT) in Stockholm.
Among those seen as possible laureates is Kevan Shokat, an American biologist who figured out how to block the KRAS cancer gene behind a third of cancers, including challenging-to-treat lung, colon and pancreatic tumours.
"These are now being tested for new treatments thanks to his discovery," said Annika Ostman, science reporter at Swedish public radio SR.
Research into how to treat cardiovascular illnesses could also get the nod, with the work of geneticists Jonathan Cohen and Helen Hobbs mentioned.
They identified genes that regulate the metabolism of essential lipids such as cholesterol, which has led to a new class of cholesterol-lowering drugs, David Pendlebury, head of the Clarivate analytics group that identifies Nobel-worthy research, told AFP.
Hobbs won the Breakthrough Prize in Life Sciences in 2016, sharing the honour with Swedish geneticist Svante Paabo, who went on to win the Nobel in 2022.
Pendlebury also spotlighted a trio of neuroscientists who have researched the basal ganglia, a region in the brain important for motivation and reward, and how it regulates our behaviour.
The three are US neuroscientist Ann Graybiel, Okihide Hikosaka of Japan and German-born Wolfram Schultz.
Other potential winners are Davor Solter and Azim Surani for their study of epigenetics, which examines how cells control the activities of genes without changing the DNA.
Last year, the medicine prize went to researchers Katalin Kariko and Drew Weissman for their work on messenger RNA technology that paved the way for groundbreaking Covid-19 vaccines.
- Atomic scale microscope -
For the Nobel Prize in Physics, announced on Tuesday, SR's science experts suggested the honour could go to Swiss physicist Christoph Gerber, a pioneer in the development of the atomic force microscope.
"This is a microscope that gives 3D images on such an incredibly small scale that they sometimes are even atomic resolution," said SR science reporter Camilla Widebeck.
The tool has become indispensable in nanotechnology and nano research, she added.
Clarivate also mentioned Gerber as a possible winner, as well as David Deutsch and Peter Shor for their work on quantum algorithms and quantum computing.
Lars Brostrom at SR meanwhile said he hoped to see American-Jordanian Omar Yaghi win Wednesday's chemistry prize.
Yaghi developed a type of customised porous material known as MOF (Metal-organic framework), now used in commercial products that can, among other things, absorb and decontaminate toxins, act as a catalyst or even absorb water from desert air.
Karl Deisseroth, a US psychiatrist and neurologist, has also been mentioned for the past decade as a possible laureate for developing the field of optogenetics, using light to control cells.
Speculation is also rife for the literature prize, to be announced on Thursday and perhaps the most highly anticipated Nobel after the peace prize.
Several pundits believe Chinese author Can Xue will be the Swedish Academy's choice this year -- and she has the lowest odds on several betting sites.
An avant-garde fiction writer often likened to Kafka, her experimental style flips between utopia and dystopia and transforms the mundane into the surreal.
"I think it will be a woman from a language zone outside Europe," Bjorn Wiman, culture editor at Sweden's newspaper of record, Dagens Nyheter, told AFP.
Others suggest it could go to Australian novelist Gerald Murnane, Britain's Salman Rushdie or Kenya's Ngugi wa Thiong'o.
- Who deserves the Peace Prize? -
The climax of the week comes Friday when the Peace Prize laureate is announced, but experts say predictions are harder than ever this year due to the growing number of crises in the world.
The UN agency for Palestinian refugees UNRWA, the International Court of Justice and Afghan women's rights activist Mahbouba Seraj have been mentioned as possibilities.
Given the existential risks to humanity posed by weapons systems that can operate autonomously without human control, several Nobel-watchers have also cited the Campaign to Stop Killer Robots as a potential laureate.
The economics prize wraps up the 2024 Nobel season on October 14.
It could go to research on the economics of child development, the integration of nature in the economy, or the effects of corruption on economic growth.
W.Huber--VB